Structural Bioinformatics Section Vaccine Research Center/NIAID/NIH

Slides:



Advertisements
Similar presentations
Production and characterization of human anti-V3 monoclonal antibodies from Indian clade C HIV-1 infected patients Raiees Andrabi AIIMS, New Delhi, India.
Advertisements

Hotspot Hunter: a computational system for large-scale screening and selection of candidate immunological hotspots in pathogen proteomes G.L. Zhang, A.M.
Office of Infectious Diseases Computational Challenges for Infectious Diseases Michael Shaw, PhD OID/Office of the Director.
Slide by eric martz, sept 2003 Antibody domain exchange is an immunological solution to carbohydrate cluster recognition. Daniel Calarese … Ian A. Wilson.
Designing and Optimizing an Adenovirus Encoded VLP Vaccine against HIV Anne-Marie Andersson PhD Student, University of Copenhagen.
Dual conformations for the HIV-1 gp120 V3 loop in complexes with different neutralizing Fabs RL Stanfield, E Cabezas, AC Satterthwait, EA Stura, AT Profy,
CENTER FOR BIOLOGICAL SEQUENCE ANALYSISTECHNICAL UNIVERSITY OF DENMARK DTU B cell epitopes and predictions Pernille Haste Andersen, Ph.d. student Immunological.
A comparative study of adaptive molecular evolution in different HIV clades Marc Choisy CEPM UMR CNRS-IRD 9926 Montpellier, France.
The branch that breaks Is called rotten, but Wasn’t there snow on it? Bartolt Brecht Haiti after a hurricane.
Influenza A Virus Pandemic Prediction and Simulation Through the Modeling of Reassortment Matthew Ingham Integrated Sciences Program University of British.
The branch that breaks Is called rotten, but Wasn’t there snow on it? Bartolt Brecht Haiti after a hurricane.
Epitope Selection Rational Vaccine design. Why? Therapeutic vaccines Therapeutic vaccines Treatment of viral infections (e.g., HIV, HCV), and resistant.
CENTER FOR BIOLOGICAL SEQUENCE ANALYSISTECHNICAL UNIVERSITY OF DENMARK DTU B cell epitopes and B cell epitope predictions Morten Nielsen, CBS, BioCentrum,
Materials and Methods Abstract Conclusions Introduction 1. Korber B, et al. Br Med Bull 2001; 58: Rambaut A, et al. Nat. Rev. Genet. 2004; 5:
Anti-idiotypes and Immunity Dr. Ziad Jaradat. Anti-idiotypes and Immunity The immune system of an individual can make millions of different kinds of antibodies:
HIV GP120 Envelope Protein
Examination of Amino Acid Differences as a Means of Determining Functional Changes in HIV-1 Protein Sequences Chris Rhodes and Isaiah Castaneda Loyola.
Methods MHC class-I T cell epitope prediction for Nef Consensus and ancestral sequences of the Nef protein for the different HIV-1 subtypes were obtained.
Jacob Glanville Neutralizing the VSG Repertoire. Trypanosoma brucei and the Variable Surface Glycoprotein (VSG)
Selection of T Cell Epitopes Using an Integrative Approach Mette Voldby Larsen cand. scient. in Biology PhD in Immunological Bioinformatics.
Conclusions Results show that the mutation at the N-linked glycosylation site N276D has a distinct influence on sensitivity to the HJ16 CD4bs neutralizing.
Statistical Tool for Identifying Sequence Variations That Correlate with Virus Phenotypic Characteristics in the Virus Pathogen Resource (ViPR) July 22,
Lab of Immunoregulation Berkower Lab Weiss Lab -- Angelo Spadaccini -- Russell Vassell -- Yisheng Ni -- Yong He -- Yisheng Ni -- Yong He –Hong Chen --
CENTER FOR BIOLOGICAL SEQUENCE ANALYSIS BiC BioCentrum-DTU Technical University of Denmark 1/31 Prediction of significant positions in biological sequences.
Dr. Jeffrey Dorfman Cellular Immunology ICGEB Cape Town Autoreactivity of anti-HIV-1 neutralizing antibodies does not prevent broad antibody responses.
A Mutational Investigation of an HIV Patient’s GP120 Glycoprotein and it’s Implications on CD4 Binding Salita Kaistha Usrinus College, Collegeville PA.
Samudrala group - overall research areas CASP6 prediction for T Å C α RMSD for all 70 residues CASP6 prediction for T Å C α RMSD for all.
Residue Sequence and Structure in the Re evaluation the Categorization of HIV Progression in Subjects Based on CD4 T cell Decline Rates Angela Garibaldi.
Towards an antibody-based HIV vaccine
Recurring conformation of the human immunodeficiency virus type 1 gp120 V3 loop Robyn L. Stanfield, Jayant B. Ghiara, Erica O. Saphire, Albert T. Profy,
Research on killer HIV antibodies provides promising new ideas for vaccine design New discoveries about the immune defenses of rare HIV patients who produce.
Role of V3 in HIV Entry and Neutralization Chloe Jones, Isabel Gonzaga, and Nicole Anguiano BIOL398: Bioinformatics Laboratory Loyola Marymount University.
Analyzing Differences in Protein Sequences Between Subjects with Varying T Cell Counts J’aime Moehlman Amanda Wavrin Loyola Marymount University March.
B cell epitopes and predictions
“Neutralizing Antibodies Derived from the B Cells of 1918 Influenza Pandemic Survivors” (Yu et. al) Daniel Greenberg.
Lecture 13 Immunology and disease: parasite antigenic diversity.
Structure of V3-containing HIV-1 gp120 core Huang, C. C., Tang, M., Zhang, M. Y., Majeed, S., Montabana, E., Stanfield, R. L., Dimitrov, D. S., Korber,
CATEGORY: VACCINES & THERAPEUTICS HIV-1 Vaccines Shokouh Makvandi-Nejad, University of Oxford, UK HIV-1 Vaccines © The copyright for this work resides.
HIV & Influenza Figure 2 | Schematic diagram of HIV‑1 and influenza A virus. Both HIV-1 and influenza A virus are approximately 80–120 nm in diameter and.
Investigations of HIV-1 Env Evolution Evolutionary Bioinformatics Education: A BioQUEST Curriculum Consortium Approach Grand Valley State University August.
CLASSIFICATION PETER H. RUSSELL, BVSc, PhD, FRCPath, MRCVS Department of Pathology and Infectious Diseases, The Royal Veterinary College, Royal College.
Intracellular Pathogens Extracellular Pathogens
The V3 Region Expresses More Diversity in Amino Acid Sequence in AIDS Diagnosed Patients than in Non-Trending and AIDS Progressing Patients HIV Structure.
Immunology and disease: parasite antigenic diversity
Volume 156, Issue 4, Pages (February 2014)
Volume 39, Issue 2, Pages (August 2013)
Peter D. Kwong, John R. Mascola  Immunity 
Volume 165, Issue 7, Pages (June 2016)
HIV Immunology Goes Out On a Limb
Volume 18, Issue 3, Pages (September 2015)
Volume 22, Issue 7, Pages (February 2018)
Structure of V3-containing HIV-1 gp120 core
LMU Department of Biology
Dual conformations for the HIV-1 gp120 V3 loop in complexes with different neutralizing Fabs RL Stanfield, E Cabezas, AC Satterthwait, EA Stura, AT Profy,
The Rational Design of an AIDS Vaccine
Loyola Marymount University
Loyola Marymount University
Nicki Harmon, Samantha Hurndon, & Zeb Russo
Volume 21, Issue 6, Pages (June 2013)
Adam S. Dingens, Hugh K. Haddox, Julie Overbaugh, Jesse D. Bloom 
Volume 21, Issue 10, Pages (December 2017)
Volume 23, Issue 3, Pages (April 2018)
Volume 153, Issue 1, Pages (March 2013)
Volume 24, Issue 8, Pages (August 2016)
Volume 7, Issue 3, Pages (May 2014)
Chloe Jones, Isabel Gonzaga, and Nicole Anguiano
Loyola Marymount University
Volume 25, Issue 6, Pages e5 (June 2019)
Volume 17, Issue 6, Pages (November 2016)
Cure of HIV infection: Is the long wait over?
Presentation transcript:

Structural Bioinformatics Section Vaccine Research Center/NIAID/NIH Application of Neutralization Fingerprinting in Antibody Epitope Prediction and Delineating Antibody Recognition in HIV-1 Sera Gwo-Yu Chuang Structural Bioinformatics Section Vaccine Research Center/NIAID/NIH September 25th, 2014

Who We Are SBIS Ivelin Georgiev Peter Kwong Computational Biology and Structural Bioinformatics Vaccine Design Structure Analysis Serum Analysis/ Antibodyomics Immunogen Ivelin Georgiev Peter Kwong

Major Epitopes Targeted by Broadly Neutralizing Antibodies On the HIV-1 Env Spike MPER-like Pancera et al. (2012) Nature (in press)

A fast and accurate method to delineate HIV-1 sera specificity Goals A fast and accurate method to predict HIV-1 antibody epitope in residue level Understand resistance mutation Facilitate optimization of neutralizing antibodies Provide basis for epitope-based vaccine design A fast and accurate method to delineate HIV-1 sera specificity Isolation of new monoclonal antibodies that may be of therapeutic value Elucidating immunodominant epitopes

Predicting HIV-1 sera specificity using neutralization fingerprinting Outline Predicting antibody epitope in residue level using neutralization fingerprint Predicting HIV-1 sera specificity using neutralization fingerprinting

Existing Methods for Epitope Prediction Experimental: Method Accuracy Efficiency Crystallography High Low NMR Cryo-EM Medium Alanine Scanning Medium/High Medium/Low Pepscan Computational: Method Accuracy Efficiency Protein Docking Low High Sequence and structure analysis

Covariation Between Neutralization Potency and Sequence Variability Basis: Altering amino acid of epitope residues is highly likely to affect neutralization Amino acid fingerprints Neutralization fingerprint 1 x y n …… …… Strain 1 …… …… Strain 2 …… …… Strain 3 …… …… Strain 4 …… …… Strain 5 …… …… Strain 6 Different amino acid types Different neutralization potency levels Chuang et al (2013), Journal of Virology

Covariation Between Neutralization Potency and Sequence Variability Basis: Altering amino acid of epitope residues is highly likely to affect neutralization Amino acid type at position x Neutralization potency Amino acid type at position y Neutralization potency Amino acid type at position x and neutralization potency have a high degree of mutual variation => Position x is likely at the epitope Amino acid type at position y and neutralization potency have a low degree of mutual variation => Position y is not likely at the epitope Different amino acid types Different neutralization potency levels Chuang et al (2013), Journal of Virology

Epitope Prediction Based on Mutual Information Between Neutralization and Sequence Variability Rank each antigen residue by the normalized mutual information between amino acid type and neutralization IC50 Mutual information calculation Amino acid type at position i Neutralization potency x: amino acid types y: neutralization IC50 values (20 aa type plus gap) discretized as neutralizing (IC50<50μg/mL) and non-neutralizing (IC50>=50μg/mL) Chuang et al (2013), Journal of Virology

Incorporating Antigen Structural Information and Epitope Propensity Score Mutual information calculation Amino acid type at position i Neutralization potency + Surface Accessibility Spatial Localization of high scoring residues Epitope propensity score (PS) (Haste-Andersen et al. 2006 Protein Sci.) Chuang et al (2013), Journal of Virology

Test Cases – 19 HIV-1 antibodies Neutralization panel (181 strains) Antibodies Viral Strains Antibody Site of Recognition VRC01 CD4-binding site VRC-PG04 b12 b13 F105 NIH45-46 3BNC117 VRC-PG20 VRC23 CH103 VRC03 VRC06 VRC-CH31 17b CD4i 10E8 MPER 2F5 4E10 PG9 V1/V2 PG16 Epitope defined by crystal structure Antibody(Fab) Antigen Antigen-antibody complex crystal structure Chuang et al (2013), Journal of Virology Likelihood of being an epitope residue: i > i+1 > i+2 >i+3

Neutralization-based Epitope Prediction Algorithms Give Good Prediction Accuracy TP (True Positive): Number of correctly predicted epitope residues FP (False Positive): Number of incorrectly predicted epitope residues TP rate= TP/(Number of epitope residues) FP rate= FP/(Number of non-epitope residues) Chuang et al (2013), Journal of Virology Likelihood of being an epitope residue: i > i+1 > i+2 >i+3

Case Study: Predicting the Epitope of HIV-1 Antibody 8ANC195 Isolated using a stabilized HIV-1 gp120 core (2CC) (Scheid et al. 2011, Science) Does not possess characteristics of CD4bs- or CD4i-antibodies No 8ANC195/gp120 complex structure available at the time of prediction

8ANC195 Epitope Prediction Top 10 predicted epitope residues HIV-1 gp120 Top 10 predicted epitope residues Glycan 276 Glycan 234 N/C termini CD4 binding site - Three of the top ten predicted residues are part of two N-linked glycosylation sequons at gp120 residues 234 and 276, suggesting that 8ANC195 might binds to these two glycans Chuang et al (2013), Journal of Virologyç

8ANC195 Binding/Neutralization is Affected by the Presence of N-linked Glycans at Residue 234 and 276 8ANC195 neutralization of 3337.V2.C6 pseudoviruses 8ANC195 binding to gp120 mutants Mutations Neutralization IC50 (μg/mL) Wild type 0.049 N234S >50 T236K N276D Chuang et al (2013), Journal of Virology

(Scharf et al (2014), Cell Reports) Predicted 8ANC195 Epitope Residues Highly Agree with Epitope Determined by Crystallography N/C termini HIV-1 gp120 8ANC195 epitope determined by crystal structure Glycan 234 Glycan 234 Top 10 predicted epitope residues Glycan 276 Glycan 276 PDB:4P9H (Scharf et al (2014), Cell Reports) 5 of the top 10 predicted residues are part of the 8ANC195 epitope Chuang et al (2013), Journal of Virology

NEP: Neutralization-based Epitope Prediction Web-Server Input: 1) Antibody neutralization data 2) Antigen sequence 3) Antigen structure (optional) http://exon.niaid.nih.gov/nep Chuang et al (2014), Nucleic Acids Research

Conclusions (I) The neutralization-based algorithm is able to predict the epitope residues of HIV-1 antibodies with good accuracy and high efficiency HIV-1 antibody 8ANC195 binds to N-linked glycans at gp120 position 234 and 276. This binding mode was not described at the time of the prediction A web-based server (NEP) is available to the public to run neutralization-based epitope prediction The method is applicable to other viruses with diverse strains (e.g. influenza)

Predicting HIV-1 sera specificity using neutralization fingerprinting Outline Predicting antibody epitope in residue level using neutralization fingerprint Predicting HIV-1 sera specificity using neutralization fingerprinting

Mapping HIV-1 Sera Specificity Peptide Interference Linear epitopes Epitope Specific Probes e.g. gp120 core Knocking out specific sites e.g N160K to knockout V1/V2 ab binding Chimeric Viruses e.g. grafting HIV-1 epitopes on SIV Binley et al. (2009) Current Opinion in HIV and AIDS . Dey et al. (2009) Plos Pathogens

Identification of Serum Specificity by Deconvolution of Neutralization Fingerprints 10E8-like PG9-like Viruses Viruses VRC01 PG9 10E8 PGT128 Georgiev et al (2013), Science

Predicted Sera Specificities Agree with Identified Neutralizing Antibodies V1/V2 specific antibody VRC26 was identified (Doria-Rose (2014), Nature) Georgiev et al (2013), Science

Predicted Sera Specificities Matched Standard Sera Mapping Georgiev et al (2013), Science

Conclusions (II) A new computational tool, based on neutralization fingerprints, was developed to predict HIV-1 sera specificities The tool can aid the identification of new anti-HIV-1 broadly neutralizing antibody and understanding of the development of broadly neutralizing antibodies during the course of infection

Acknowledgments Structural Bioinformatics Section Peter Kwong Ivelin Georgiev BSL3 Core Virology Section John Mascola Nicole Doria-Rose Ryan Staupe Mark K. Louder Stephen Schmidt Krisha McKee Sijy O’Dell Structural Biology Section Peter Kwong Priyamvada Acharya Jason Gorman Young Do Kwon Marie Pancera Yongping Yang Baoshan Zhang Tongqing Zhou Immunology Core Section Robert Bailer Office of Cyber Infrastructure and Computational Biology David Liou